相似文献
1
The preparation, purification, and amino acid sequence of a polypeptide renin substrate.
J Exp Med. 1957 Sep 1;106(3):439-53. doi: 10.1084/jem.106.3.439.
2
Kinetics of the reaction of renin with nine synthetic peptide substrates.
J Exp Med. 1968 Jul 1;128(1):13-34. doi: 10.1084/jem.128.1.13.
3
Renin cleavage of a human kidney renin substrate analogous to human angiotensinogen, H-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Val-Ile-His-Ser-OH, that is human renin specific and is resistant to cathepsin D.
Anal Biochem. 1984 Aug 1;140(2):459-67. doi: 10.1016/0003-2697(84)90194-5.
4
Synthesis and renin inhibitory activity of angiotensinogen analogues having dehydrostatine, Leu psi [CH2S]Val, or Leu psi [CH2SO]Val at the P1-P1' cleavage site.
J Med Chem. 1988 Jul;31(7):1377-82. doi: 10.1021/jm00402a022.
5
Potent in vivo inhibitors of rat renin: analogues of human and rat angiotensinogen sequences containing different classes of pseudodipeptides at the scissile site.
J Pept Res. 1997 Oct;50(4):239-47. doi: 10.1111/j.1399-3011.1997.tb01465.x.
6
The His-Pro-Phe motif of angiotensinogen is a crucial determinant of the substrate specificity of renin.
Biol Chem. 2007 Feb;388(2):237-46. doi: 10.1515/BC.2007.026.
7
The amino acid sequence of hypertensin. II.
J Exp Med. 1956 Aug 1;104(2):193-7. doi: 10.1084/jem.104.2.193.
8
Conformations of synthetic tetradecapeptide renin substrate and of angiotensin I in aqueous solution.
Biochemistry. 1977 Jun 14;16(12):2606-11. doi: 10.1021/bi00631a005.
9
On the specificity of human renin. Studies with peptide inhibitors.
Biochim Biophys Acta. 1976 Dec 8;452(2):533-7. doi: 10.1016/0005-2744(76)90205-9.
10
Granulocyte-angiotensin system. Identification of angiotensinogen as the plasma protein substrate of leukocyte cathepsin G.
Biochemistry. 1984 Jan 17;23(2):227-32. doi: 10.1021/bi00297a009.
引用本文的文献
1
Renin-Angiotensin System: Updated Understanding and Role in Physiological and Pathophysiological States.
Cureus. 2023 Jun 21;15(6):e40725. doi: 10.7759/cureus.40725. eCollection 2023 Jun.
2
Renin inhibitors versus angiotensin converting enzyme (ACE) inhibitors for primary hypertension.
Cochrane Database Syst Rev. 2020 Oct 22;10(10):CD012569. doi: 10.1002/14651858.CD012569.pub2.
3
Pathological Role of Angiotensin II in Severe COVID-19.
TH Open. 2020 Jun 26;4(2):e138-e144. doi: 10.1055/s-0040-1713678. eCollection 2020 Apr.
4
Clinical efficacy, safety and tolerability of Aliskiren Monotherapy (AM): an umbrella review of systematic reviews.
BMC Cardiovasc Disord. 2020 Apr 17;20(1):179. doi: 10.1186/s12872-020-01442-z.
5
Decades-old renin inhibitors are still struggling to find a niche in antihypertensive therapy. A fleeting look at the old and the promising new molecules.
Bioorg Med Chem. 2020 May 15;28(10):115466. doi: 10.1016/j.bmc.2020.115466. Epub 2020 Mar 28.
6
Normalizing Plasma Renin Activity in Experimental Dilated Cardiomyopathy: Effects on Edema, Cachexia, and Survival.
Int J Mol Sci. 2019 Aug 9;20(16):3886. doi: 10.3390/ijms20163886.
7
Renin Activity in Heart Failure with Reduced Systolic Function-New Insights.
Int J Mol Sci. 2019 Jun 28;20(13):3182. doi: 10.3390/ijms20133182.
8
Murine -linked hydrocephalus is caused by hyperpermeability of the choroid plexus.
EMBO Mol Med. 2019 Jan;11(1). doi: 10.15252/emmm.201809540.
9
Cod Residual Protein Prevented Blood Pressure Increase in Zucker fa/fa Rats, Possibly by Inhibiting Activities of Angiotensin-Converting Enzyme and Renin.
Nutrients. 2018 Nov 22;10(12):1820. doi: 10.3390/nu10121820.
10
Plasma renin activity in patients with heart failure and reduced ejection fraction on optimal medical therapy.
J Renin Angiotensin Aldosterone Syst. 2017 Jul-Sep;18(3):1470320317729919. doi: 10.1177/1470320317729919.
本文引用的文献
1
Artificial kidney; construction and operation of an improved continuous dialyzer.
Proc Soc Exp Biol Med. 1949 Dec;72(3):539-43. doi: 10.3181/00379727-72-17491.
2
The assay of hypertensin from the arterial blood of normotensive and hypertensive human beings.
J Exp Med. 1952 Jun;95(6):523-9. doi: 10.1084/jem.95.6.523.
3
The isolation and assay of hypertensin from blood.
J Exp Med. 1952 Mar;95(3):241-6. doi: 10.1084/jem.95.3.241.
4
Chromatography of amino acids on sulfonated polystyrene resins.
J Biol Chem. 1951 Oct;192(2):663-81.
5
The isolation of hypertensin from the circulating blood of normal dogs with experimental renal hypertension by dialysis in an artificial kidney.
Circulation. 1951 Mar;3(3):384-9. doi: 10.1161/01.cir.3.3.384.
6
Recent developments in techniques for terminal and sequence studies in peptides and proteins.
Methods Biochem Anal. 1955;2:359-425. doi: 10.1002/9780470110188.ch12.
7
Corticotropins (ACTH). II. Amino acid composition of alpha-corticotropin.
J Biol Chem. 1955 Mar;213(1):187-96.
8
The amino acid sequence of hypertensin. II.
J Exp Med. 1956 Aug 1;104(2):193-7. doi: 10.1084/jem.104.2.193.
9
The amino acid composition of hypertensin II and its biochemical relationship to hypertensin I.
J Exp Med. 1956 Aug 1;104(2):183-91. doi: 10.1084/jem.104.2.183.
10
The purification of hypertensin II.
J Exp Med. 1956 Mar 1;103(3):301-7. doi: 10.1084/jem.103.3.301.
Zotero 插件